Stay updated on Safety Efficacy MAT9001 in Hypertriglyceridemia Clinical Trial
Sign up to get notified when there's something new on the Safety Efficacy MAT9001 in Hypertriglyceridemia Clinical Trial page.

Latest updates to the Safety Efficacy MAT9001 in Hypertriglyceridemia Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe Record History now includes Revision: v3.3.3; the HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedRevision: v3.3.2 was added and revision v3.3.1 was removed from the Record History page. This update does not modify study data or critical information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check43 days agoChange DetectedThe Record History now shows revision v3.3.1 added and v3.2.0 removed in the version list. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check50 days agoChange DetectedRemoved the government funding lapse notice, an administrative banner about potential delays and operating status that was not related to the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check64 days agoChange DetectedVersion history shows updates adding and updating the Study Status, Recruitment Status, and Study Design sections, along with Contacts/Locations.SummaryDifference0.1%

- Check93 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference13%

Stay in the know with updates to Safety Efficacy MAT9001 in Hypertriglyceridemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Efficacy MAT9001 in Hypertriglyceridemia Clinical Trial page.